MHRA: Suspected adverse reactions to flu antivirals and vaccines confirm recognised safety profile

How to reduce your risk of contracting swine flu:

Do not travel to areas known to be affected.

Minimize the amount of time spent on public transport especially aeroplanes.

Avoided crowded public places, especially those using recirculated air conditioned air

Wear a surgical grade face mask and ensure it is fitted correctly so that it covers your nose as well as your mouth.

Refrain from touching your mouth with your hands or fingers if they may have come into contact with surfaces contiminated with the virus.

Carefully wipe any surfaces that may have come into contact with carriers such as door handles, toilet flushers, work surfaces and telephones

MHRA: Suspected adverse reactions to flu antivirals and vaccines confirm recognised safety profile

Source: MHRA
Area: Evidence > Medication Safety
The February 2010 issue of Drug Safety Update from the MHRA contains an article updating reports of suspected adverse reactions received up to 19th Jan 2010 for the antiviral medicines (oseltamivir and zanamivir) and vaccines (Celvapan® and Pandemrix®) in use to help manage swine flu.
No unexpected new safety issues have been identified from reports received to date for the vaccines, and no new issues have been identified with oseltamivir and zanamivir. The safety of these medicines will continue to be kept under close review; any suspected adverse reactions can be reported via www.mhra.gov.uk/swineflu . Please see the link below for details. (Source: NeLM - Patient Safety)

Comments are closed.

Current Status

Protection Steps

MHRA: Suspected adverse reactions to flu antivirals and vaccines confirm recognised safety profile

Flu Protection

Recent Features